| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.4 |